Search

exendin-4 based dual GLP-1/glucagon receptor agonist
Authors
Evers, A., Kurz, M.
Assembly
Exendin-4
Entity
1. Exendin-4, entity 1 (polymer, Thiol state: not present), 40 monomers, 4137.544 Da Detail

HXQGTFTSDL SKQKDEQRAK LFIEWLXAGG PSSGAPPPSX


2. Exendin-4, entity EVT (non-polymer), 514.652 Da
Total weight
4652.196 Da
Max. entity weight
4137.544 Da
Source organism
Heloderma suspectum
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 92.5 %, Completeness: 97.3 %, Completeness (bb): 94.6 % Detail

Polymer type: polypeptide(L)

Total1H
All97.3 % (216 of 222)97.3 % (216 of 222)
Backbone94.6 % (70 of 74)94.6 % (70 of 74)
Sidechain98.6 % (146 of 148)98.6 % (146 of 148)
Aromatic100.0 % (18 of 18)100.0 % (18 of 18)
Methyl100.0 % (13 of 13)100.0 % (13 of 13)

1. entity 1

HXQGTFTSDL SKQKDEQRAK LFIEWLXAGG PSSGAPPPSX

Sample

Solvent system trifluoroethanol/water, Pressure 1 (±0.01) Pa, Temperature 310 (±0.2) K, pH 5.0 (±0.05), Details 5 mg/mL Peptide 5, trifluoroethanol/water


#NameIsotope labelingTypeConcentration
1Peptide 5natural abundance5 mg/mL
2sodium phosphatenatural abundance35 mM

Release date
2018-06-17
Citation
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations
Evers, A., Bossart, M., Pfeiffer-Marek, S., Elvert, R., Schreuder, H.A., Kurz, M., Stengelin, S., Lorenz, M., Herling, A., Konkar, A.A., Lukasczyk, U., Pfenninger, A., Lorenz, K., Haack, T., Kadereit, D., Wagner, M.
J. Med. Chem. (2018), 61, 5580-5593, PubMed 29879354 , DOI 10.1021/acs.jmedchem.8b00292 ,
Related entities 1. Exendin-4, entity 1, : 1 : 39 entities Detail
Experiments performed 4 experiments Detail
nullKeywords HORMONE